Tumour Markers and Molecular Imaging with FDG PET/CT in Breast Cancer: Their Combination for Improving the Prediction of Disease Relapse

Documenti analoghi

• 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging
  di: Ana Paula Caresia Aroztegui, et al.
  Pubblicazione: (2017-10-01)
• Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
  di: Shiqing Liu, et al.
  Pubblicazione: (2025-08-01)
• Dedifferentiated liposarcoma lung metastases with different FDG-PET/CT findings
  di: Yoshito Imamura, et al.
  Pubblicazione: (2023-05-01)
• Axillary staging with 18F-FDG PET/CT in early breast cancer: impact of tumor subtypes
  di: Abdullah Gunes, et al.
  Pubblicazione: (2025-05-01)
• ¹⁸F-FDG PET/CT in the Diagnosis of Cervical Cancer
  di: A. V. Leontyev, et al.
  Pubblicazione: (2022-12-01)